Grants and Contributions:
Title:
COVID-19 - Feasibility of a RAMP Multiplex Assay Format
Agreement Number:
1002372
Agreement Value:
$316,575.00
Agreement Date:
Jan 1, 2023 - Mar 31, 2023
Description:
Covid-19 - Feasibility of a RAMP Multiplex Assay Format
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6P 6P2
Reference Number:
172-2022-2023-Q4-1002372
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
121519920
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 316,575 dollars.
Amendment Date
Mar 21, 2023
Recipient's Operating Name:
Response Biomedical
Recipient's Legal Name:
Response Biomedical Corp.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: